TY - JOUR
T1 - Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning
AU - Cui, Yijun
AU - Costa, Rui M.
AU - Murphy, Geoffrey G.
AU - Elgersma, Ype
AU - Zhu, Yuan
AU - Gutmann, David H.
AU - Parada, Luis F.
AU - Mody, Istvan
AU - Silva, Alcino J.
N1 - Funding Information:
This work was supported by grants from the NIH (R01 NS38480), Neurofibromatosis Inc., the Children's Tumor Foundation, and United States Army (W81XWH-06-1-0174) to A.J.S. and NS30549 and the Coelho Endowment to I.M. This work was also supported by a generous donation from C.M. Spivak to A.J.S. Y.C. was supported by a fellowship from the Children's Tumor Foundation. We thank P. Greengard and J.N. Jovanovic for the generous gift of the phospho-Syn I antibodies. We are grateful to Steven Kushner, Brandon M. Stell, and Weizheng Wei for fruitful discussions.
PY - 2008/10/31
Y1 - 2008/10/31
N2 - We uncovered a role for ERK signaling in GABA release, long-term potentiation (LTP), and learning, and show that disruption of this mechanism accounts for the learning deficits in a mouse model for learning disabilities in neurofibromatosis type I (NF1). Our results demonstrate that neurofibromin modulates ERK/synapsin I-dependent GABA release, which in turn modulates hippocampal LTP and learning. An Nf1 heterozygous null mutation, which results in enhanced ERK and synapsin I phosphorylation, increased GABA release in the hippocampus, and this was reversed by pharmacological downregulation of ERK signaling. Importantly, the learning deficits associated with the Nf1 mutation were rescued by a subthreshold dose of a GABAA antagonist. Accordingly, Cre deletions of Nf1 showed that only those deletions involving inhibitory neurons caused hippocampal inhibition, LTP, and learning abnormalities. Importantly, our results also revealed lasting increases in GABA release triggered by learning, indicating that the mechanisms uncovered here are of general importance for learning.
AB - We uncovered a role for ERK signaling in GABA release, long-term potentiation (LTP), and learning, and show that disruption of this mechanism accounts for the learning deficits in a mouse model for learning disabilities in neurofibromatosis type I (NF1). Our results demonstrate that neurofibromin modulates ERK/synapsin I-dependent GABA release, which in turn modulates hippocampal LTP and learning. An Nf1 heterozygous null mutation, which results in enhanced ERK and synapsin I phosphorylation, increased GABA release in the hippocampus, and this was reversed by pharmacological downregulation of ERK signaling. Importantly, the learning deficits associated with the Nf1 mutation were rescued by a subthreshold dose of a GABAA antagonist. Accordingly, Cre deletions of Nf1 showed that only those deletions involving inhibitory neurons caused hippocampal inhibition, LTP, and learning abnormalities. Importantly, our results also revealed lasting increases in GABA release triggered by learning, indicating that the mechanisms uncovered here are of general importance for learning.
KW - MOLNEURO
UR - http://www.scopus.com/inward/record.url?scp=54549106766&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2008.09.060
DO - 10.1016/j.cell.2008.09.060
M3 - Article
C2 - 18984165
AN - SCOPUS:54549106766
SN - 0092-8674
VL - 135
SP - 549
EP - 560
JO - Cell
JF - Cell
IS - 3
ER -